Skip to main content
. Author manuscript; available in PMC: 2012 May 3.
Published in final edited form as: J Gastrointest Surg. 2008 Aug 16;12(11):1951–1960. doi: 10.1007/s11605-008-0640-6

Figure 5.

Figure 5

Patient overall survivals by primary tumor type: median survival for carcinoids (solid line) was 45.0 months while islet cell tumors (dotted line) had a median survival of 32.0 months. This difference was not statistically significant (p=0.84).